tirzepatide weight loss cleveland oh New 'weight-loss' drugs have lower impact in real life: study-The Hindu, 11/06/2025 Article Analysis -Health๐๐ฝ A study conducted by researchers from the Clinic, Ohio, published in the journal Obesity on June Weight-Loss Drug Tirzepatide Reduces Severity
Description
Current or history of pancreatitis 8
Serious adverse events were reported in a higher proportion of patients who received tirzepatide compared to semaglutide
Have severe digestive issues, or a history of pancreatitis or thyroid cancer
Injecting too quickly can cause discomfort and may increase the risk of leakage
Some patients lose 15 to 20 percent of body weight within six months
These effects are typically mild and decrease with time
